Show simple item record

Inhibition of B-cell death does not restore T-cell-dependent immune responses in CD40-deficient mice

dc.contributor.authorMerino, Jesúsen_US
dc.contributor.authorDíez, Miguel A.en_US
dc.contributor.authorMuñiz, Maríaen_US
dc.contributor.authorBuelta, Luisen_US
dc.contributor.authorNúñez, Gabrielen_US
dc.contributor.authorLópez-Hoyos, Marcosen_US
dc.contributor.authorMerino, Ramónen_US
dc.date.accessioned2010-06-01T22:01:24Z
dc.date.available2010-06-01T22:01:24Z
dc.date.issued2003-08en_US
dc.identifier.citationMerino, JesÚs; DÍez, Miguel A.; MuÑiz, MarÍa; Buelta, Luis; NÚÑez, Gabriel; LÓpez-Hoyos, Marcos; Merino, RamÓn (2003). "Inhibition of B-cell death does not restore T-cell-dependent immune responses in CD40-deficient mice." Immunology 109(4): 504-509. <http://hdl.handle.net/2027.42/75051>en_US
dc.identifier.issn0019-2805en_US
dc.identifier.issn1365-2567en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75051
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12871216&dopt=citationen_US
dc.description.abstractSignalling through CD40 is essential for the development of immunoglobulin G (IgG) antibody responses, germinal centres and B-cell memory against T-dependent antigens. In addition, engagement of CD40 in B cells promotes cell survival by inducing the expression of anti-apoptotic members of the bcl-2 family of cell-death regulators. In the present study we analysed whether T-dependent immune responses can be developed in mice deficient in CD40 if the anti-apoptotic activity mediated by the engagement of CD40 in B cells is compensated by the constitutive over-expression of anti-apoptotic genes of the bcl-2 family. We showed that the over-expression of either hbcl-2 or hbcl-x L transgenes in B cells is not sufficient to restore IgG antibody responses and germinal centre formation in CD40-deficient mice. These results indicate that CD40 functions, other than those mediated through survival, are required for the establishment of T-dependent B-cell responses.en_US
dc.format.extent228652 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science, Ltden_US
dc.rights© 2003 Blackwell Publishing Ltden_US
dc.titleInhibition of B-cell death does not restore T-cell-dependent immune responses in CD40-deficient miceen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMicrobiology and Immunologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationum† Department of Pathology, University of Michigan, Ann Arbor, MI, USA,en_US
dc.contributor.affiliationother* Laboratory of Immunology, Department of Molecular Biology, (Unit associated with CIB/CSIC), University of Cantabria, Santander, Spain,en_US
dc.contributor.affiliationother† Department of Medical and Surgery Sciences, University of Cantabria, Santander, Spain,en_US
dc.contributor.affiliationother§ Immunology anden_US
dc.contributor.affiliationother¶ Research Unit, Hospital Universitario MarquÉs de Valdecilla, Santander, Spainen_US
dc.identifier.pmid12871216en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75051/1/j.1365-2567.2003.01690.x.pdf
dc.identifier.doi10.1046/j.1365-2567.2003.01690.xen_US
dc.identifier.sourceImmunologyen_US
dc.identifier.citedreferencevan Kooten C, Banchereau J. CD40–CD40 ligand. J Leukoc Biol 2000; 67: 2 – 17.en_US
dc.identifier.citedreferenceFoy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 1996; 14: 591 – 617.en_US
dc.identifier.citedreferenceKawabe T, Naka T, Yoshida K et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994; 1: 167 – 78.en_US
dc.identifier.citedreferenceXu J, Foy TM, Laman JD et al. Mice deficient for the CD40 ligand. Immunity 1994; 1: 423 – 31.en_US
dc.identifier.citedreferenceCallard RE, Armitage RJ, Fanslow WC, Spriggs MK. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 1993; 14: 559 – 64.en_US
dc.identifier.citedreferenceHolder MJ, Wang H, Milner AE et al. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur J Immunol 1993; 23: 2368 – 71.en_US
dc.identifier.citedreferenceMerino R, Grillot DA, Simonian PL, Muthukkumar S, Fanslow WC, Bondada S, Nunez G. Modulation of anti-IgM-induced B cell apoptosis by Bcl-x L and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody–IgM receptor interaction. J Immunol 1995; 155: 3830 – 8.en_US
dc.identifier.citedreferenceGrillot DA, Merino R, Pena JC, Fanslow WC, Finkelman FD, Thompson CB, Nunez G. bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J Exp Med 1996; 183: 381 – 91.en_US
dc.identifier.citedreferenceTuscano JM, Druey KM, Riva A, Pena J, Thompson CB, Kehrl JH. Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center. Blood 1996; 88: 1359 – 64.en_US
dc.identifier.citedreferenceGrumont RJ, Rourke IJ, Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev 1999; 13: 400 – 11.en_US
dc.identifier.citedreferenceLee HH, Dadgostar H, Cheng Q, Shu J, Cheng G. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signalling in B lymphocytes. Proc Natl Acad Sci USA 1999; 96: 9136 – 41.en_US
dc.identifier.citedreferenceDadgostar H, Zarnegar B, Hoffmann A, Qin XF, Truong U, Rao G, Baltimore D, Cheng G. Cooperation of multiple signalling pathways in CD40-regulated gene expression in B lymphocytes. Proc Natl Acad Sci USA 2002; 99: 1497 – 502.en_US
dc.identifier.citedreferenceStrasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris AW. Enforced Bcl2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 1991; 88: 8661 – 5.en_US
dc.identifier.citedreferenceMerino R, Ding L, Veis DJ, Korsmeyer SJ, Nunez G. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J 1994; 13: 683 – 91.en_US
dc.identifier.citedreferenceKikuchi T, Worgall S, Singh R, Moore MA, Crystal RG. Dendritic cells genetically modified to express CD40 ligand and pulsed with antigen can initiate antigen-specific humoral immunity independent of CD4 + T cells. Nat Med 2000; 6: 1154 – 9.en_US
dc.identifier.citedreferenceJabara HH, Laouini D, Tsitsikov E et al. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity 2002; 17: 265 – 76.en_US
dc.identifier.citedreferenceUchida J, Yasui T, Takaoka-Shichijo Y, Muraoka M, Kulwichit W, Raab-Traub N, Kikutani H. Mimicry of CD40 signals by Epstein–Barr virus LMP1 in B lymphocyte responses. Science 1999; 286: 300 – 3.en_US
dc.identifier.citedreferenceDahl AM, Klein C, Andres PG, London CA, Lodge MP, Mulligan RC, Abbas AK. Expression of bcl-X (L) restores cell survival, but not proliferation of effector differentiation, in CD28-deficient T lymphocytes. J Exp Med 2000; 191: 2031 – 8.en_US
dc.identifier.citedreferenceOxenius A, Campbell KA, Maliszewski CR, Kishimoto T, Kikutani H, Hengartner H, Zinkernagel RM, Bachmann MF. CD40–CD40 ligand interactions are critical in T–B cooperation but not for other antiviral CD4 + T cell functions. J Exp Med 1996; 183: 2209 – 18.en_US
dc.identifier.citedreferenceBuhlmann JE, Gonzalez M, Ginther B et al. Sustained expansion of CD8 + T cells requires CD154 expression by Th cells in acute graft versus host disease. J Immunol 1999; 162: 4373 – 6.en_US
dc.identifier.citedreferenceFoy TM, Page DM, Waldschmidt TJ et al. An essential role for gp39, the CD40 ligand, in thymic selection. J Exp Med 1994; 182: 1377 – 88.en_US
dc.identifier.citedreferenceFillatreau S, Gray D. T cell accumulation in B cell follicles is regulated by dendritic cells and is independent of B cell activation. J Exp Med 2003; 197: 195 – 206.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.